Schuchat A, Robinson K, Wenger JD.
 et al.  Bacterial meningitis in the United States in 1995: Active Surveillance
Team.  N Engl J Med.1997;337:970-976.
Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States: an emerging
threat.  JAMA.1995;273:383-389.
Woods CW, Rosenstein N, Perkins BA. Neisseria
meningitidis outbreaks in the United States, 1994-97. In: Program
and abstracts of the 36th Annual Meeting of the Infectious Diseases
Society of America; November 12-15, 1998; Denver, Colo. Abstract 125.
Not Available.  Control and prevention of serogroup C meningococcal
disease: evaluation and management of suspected outbreaks:
recommendations of the Advisory Committee on Immunization Practices
(ACIP).  MMWR Morb Mortal Wkly Rep.1997;46:13-21.
Jackson LA, Schuchat A, Gorsky RD, Wenger JD. Should
college students be vaccinated against meningococcal disease? a
cost-benefit analysis.  Am J Public Health.1995;85:843-845.
Brundage JF, Zollinger WD. Evolution of meningococcal
disease in the U.S. Army. In: Vedros NA, ed. Evolution of
Meningococcal Disease. Boca Raton, Fla: CRC Press; 1987:5-25.
Harrison LH, Elliott JA, Dwyer DM.
 et al.  Serotype
distribution of invasive group B streptococcal isolates in Maryland:
implications for vaccine formulation.  J Infect Dis.1998;177:998-1002.
Fischer M, Harrison L, Farley M.
 et al.  Risk factors for
sporadic meningococcal disease in North America. In: Program and
abstracts of the 36th Annual Meeting of the Infectious Diseases Society
of America; November 12-15, 1998; Denver, Colo. Abstract 552.
Nguyen-Van-Tam JS, Neal KR, Monk P, O'Brien SJ, Stuart J, Ramsay M. Invasive meningococcal disease among university
undergraduates: association with catered halls of residence. Paper
presented at: 11th International Pathogenic Neisseria Conference;
November 1-6, 1998; Nice, France.
Froeschle JE. Meningococcal disease in college students
[letter].  Clin Infect Dis.In press.
Imrey PB, Jackson LA, Ludwinski PH.
 et al.  Meningococcal carriage, alcohol consumption, and campus bar patronage
in a serogroup C meningococcal disease outbreak.  J Clin
Microbiol.1995;33:3133-3137.
Imrey PB, Jackson LA, Ludwinski PH.
 et al.  Outbreak of
serogroup C meningococcal disease associated with campus bar patronage.  Am J Epidemiol.1996;143:624-630.
Fischer M, Hedberg K, Cardosi P.
 et al.  Tobacco smoke
as a risk factor for meningococcal disease.  Pediatr Infect Dis
J.1997;16:979-983.
Jackson LA, Wenger JD. Laboratory-based surveillance
for meningococcal disease in selected areas, United States, 1989-1991.  MMWR CDC Surveill Summ.1993;42(2):21-30.
Moore PS. Meningococcal meningitis in sub-Saharan
Africa: a model for the epidemic process.  Clin Infect Dis.1992;14:515-525.
Harrison LH. The worldwide prevention of meningococcal
infection: still an elusive goal [editorial].  JAMA.1995;273:419-421.
Rosenstein N, Levine O, Taylor JP.
 et al.  Efficacy of
meningococcal vaccine and barriers to vaccination.  JAMA.1998;279:435-439.
Broome CV. The carrier state: Neisseria
meningitidis.  J Antimicrob Chemother.1986;18(suppl A):25-34.
Harrison LH, Broome CV. The epidemiology of
meningococcal meningitis in the U.S. civilian population. In: Vedros
NA, ed. Evolution of Meningococcal Disease. Boca Raton, Fla:
CRC Press; 1987:27-45.
Not Available.  Serogroup Y meningococcal disease—Illinois, Connecticut, and selected areas, United States, 1989-1996.  MMWR
Morb Mortal Wkly Rep.1996;45:1010-1013.
Roberts CL, Roome A, Algert CS.
 et al.  A meningococcal
vaccination campaign on a university campus: vaccination rates and
factors in nonparticipation.  Am J Public Health.1996;86:1155-1158.
Not Available.  Control and prevention of meningococcal disease:
recommendations of the Advisory Committee on Immunization Practices
(ACIP)Â Â MMWR Morb Mortal Wkly Rep.1997;46:1-10.